Heat-shock transcription factor (HSF) family members function in stress protection and in human diseases including proteopathies, neurodegeneration and cancer. The mechanisms that drive distinct post-translational modifications, cofactor recruitment and target-gene activation for specific HSF paralogs are unknown. We present crystal structures of the human HSF2 DNA-binding domain (DBD) bound to DNA, revealing an unprecedented view of HSFs that provides insights into their unique biology. The HSF2 DBD structures resolve a new C-terminal helix that directs wrapping of the coiled-coil domain around DNA, thereby exposing paralog-specific sequences of the DBD surface for differential post-translational modifications and cofactor interactions. We further demonstrate a direct interaction between HSF1 and HSF2 through their coiled-coil domains. Together, these features provide a new model for HSF structure as the basis for differential and combinatorial regulation, which influences the transcriptional response to cellular stress. npg
a r t i c l e s HSFs are found in eukaryotes including fungi and humans, and they affect diverse aspects of cell biology including stress adaptation, protein folding and quality control, development and disease [1] [2] [3] . The remarkable diversity of HSF-target genes contributes to the influence of HSF in a wide range of cellular processes 4, 5 . Despite the recognition that HSFs have prominent roles in cellular adaptation to stress and in disease, understanding of the mechanisms by which distinct HSF paralogs bind to genomic loci and engage in unique interactions with regulatory factors is limited. A better understanding of HSF structure, interactions and function will benefit the development of therapeutic strategies that modulate HSFs for the treatment of human diseases 6, 7 .
The human HSF family comprises three members: HSF1, HSF2 and HSF4 (ref. 3) . HSFs are multidomain transcription factors containing an N-terminal winged helix-turn-helix DBD, an adjacent extended coiled-coil multimerization domain, a central regulatory domain, a C-terminal coiled-coil domain and a transcriptional-activation domain [8] [9] [10] [11] [12] . When activated, HSFs bind to a conserved DNA sequence known as a heat-shock element (HSE). HSEs consist of inverted repeats of 5′-NGAAN-3′ and exhibit variations in sequence and geometry in target genes across the human genome 5, 13, 14 . Moreover, HSF family members interpret a diverse array of regulatory inputs that enable sophisticated tuning of the transcriptional response to stress stimuli. Understanding the specific regulatory modalities of HSF family members could allow targeting of specific arms of the HSF-mediated transcriptional response.
HSF1, the most studied member of the human HSF family, has roles in the inducible transcription of genes encoding protein chaperones and the chaperonin TRiC; components of the ubiquitinproteasome and autophagy pathway for degradation of misfolded proteins; and antiapoptotic proteins and stress adaptation factors upregulated after proteotoxic stress 15, 16 . Under normal conditions, HSF1 is maintained in a repressed monomeric state through functional interactions with the Hsp90 chaperone and direct interactions with the chaperonin TRiC 3, 15 . In response to proteotoxic stress, HSF1 multimerizes through the extended coiled-coil domain, accumulates in the nucleus and promotes target-gene transcription. In addition to activating the protein quality-control machinery in response to proteotoxic stress, HSF1 activates a large constellation of genes that are influenced by different cellular contexts. For example, in cancer cells, HSF1 promotes the transcription of a subset of prosurvival genes that only partially overlap with genes that are activated in response to heat stress 5, 17 . Moreover, the genomic binding fingerprint of HSF1 in striatal neuronal cells expressing a pathological polyglutamineexpanded Huntingtin protein is distinct from that in cells expressing a nonpathogenic variant of Huntingtin 18 . These observations highlight the importance of understanding the mechanistic features of HSF1 target-gene recognition and activation in a contextdependent manner.
Like HSF1, HSF2 participates in the transcriptional regulation of genes in response to stress and has a similar overall domain structure, but it exhibits genomic binding-site occupancy and regulatory interactions that are distinct from those of HSF1 (refs. 13,19) . One of the most striking contrasts in HSF1 and HSF2 regulation is their relative stability: HSF1 is much longer lived than HSF2 in the presence a r t i c l e s of proteotoxic stimuli 20, 21 . HSF2 is recognized as a critical mediator of brain development, and it has a role in fetal alcohol syndrome 22 . In addition, both HSF1 and HSF2 contribute to spermatogenesis, and specific mutations in HSF2 have been associated with idiopathic azoospermia [23] [24] [25] . Several studies have identified a functional interaction between HSF1 and HSF2 and have observed that HSF1 and HSF2 are found in a complex in vivo 22, 26, 27 . However, the nature of the HSF1 and HSF2 interactions and their functional consequences are not well understood. Furthermore, the repertoire of target genes of HSF1 and HSF2 in different cellular contexts has only recently been explored. A study using chromatin immunoprecipitation (ChIP) and massively parallel DNA sequencing has identified the spectrum of HSF1 and HSF2 target genes in human K562 cells and has found that, although they bind similar HSE sequence motifs, HSF1 and HSF2 exhibit only a partially overlapping pattern of genomic occupancy 13 . This observation raises the interesting question of whether selection of target genes of HSF1 and HSF2 is driven by intrinsic biochemical differences between the two proteins or is mediated by extrinsic factors such as protein-protein interactions and post-translational modifications.
Current knowledge of the HSF structure is very limited. Since the elucidation of the partial structure of the HSF DBD of the yeast Kluyveromyces lactis, little structural information has been reported for any HSF 8 . To gain structural insights with respect to HSF2 DNA binding, we solved two high-resolution crystal structures of the human HSF2 DBD bound to two distinct HSEs at 1.73 Å and 2.10 Å. These structures revealed new structural features that effectively invert current models of HSF DNA binding. Moreover, we demonstrate that the unique structural features identified in this study affect human HSF regulation in vitro and in vivo. Together, these critical insights into the architecture of HSFs bound to DNA lay a mechanistic groundwork for understanding how HSF structure drives combinatorial regulation that can enable precise control of target-gene transcription at specific loci and in specific physiological and pathophysiological contexts.
RESULTS

Structure of the HSF2 DBD bound to a 'two-site' HSE
We solved the crystal structure of the human HSF2 DBD bound to a two-site HSE (5′-GGTTCTAGAACC-3′; underlines indicate individual binding sites), at 1.73 Å ( Table 1 and Supplementary Fig. 1a ). The structure shows two HSF2 monomers bound to the two-site HSE, thus creating a dimer interface parallel to the axis of DNA (Fig. 1a) . The sequence-specific interaction is largely mediated through a hydrogenbonding interaction between Arg63 and the guanine of the NGAAN HSE motif (Fig. 1b,c and Supplementary Fig. 1b ). This arginine, which is conserved and is critical for DNA binding 8 , is located within a recognition helix containing the conserved sequence SFVRQ and is inserted into the major groove of DNA ( Fig. 1a) . In addition, numerous direct and indirect (water-mediated) contacts are made between the DBD and the DNA phosphate backbone ( Fig. 1b) .
A particularly interesting non-sequence specific DNA contact involves Lys72 and the phosphate backbone ( Fig. 1b and Supplementary Fig. 1d ). This lysine corresponds to Lys80 in HSF1, which has previously been identified as being subject to acetylationmediated inhibition of DNA binding 28 . By analogy, the HSF2 DBD structure provides empirical evidence for direct contact between Lys72 and the DNA phosphate backbone (Supplementary Fig. 1d ). Although site-specific analysis of HSF2 acetylation is lacking, these results suggest that HSF2 DNA binding could be regulated in a similar fashion to that of HSF1.
A direct comparison of the HSF2 DBD structure with the K. lactis DBD structure revealed new insights into the HSF2 structures (difference distance matrix calculated between pairs of like atoms in the human HSF2 and K. lactis DBD in Fig. 1d and alignment in Supplementary Fig. 1c ). Although the DNA-binding helix, encompassing Arg63, exhibits little structural deviation, structural features distal to the DNA-binding surface are strikingly distinct. Moreover, the HSF2 structures presented here resolve two entirely new components of the DBD, which include the wing domain and a C-terminal helix (Fig. 1d) .
HSF2 wing-domain topology
The wing domains of other winged helix-turn-helix transcription factors function in direct DNA binding 8, 28, 29 . Although previous structural studies of the K. lactis HSF DBD have not resolved the wing domain, our structure of the human HSF2 wing domain showed clear electron density for the entirety of the peptide backbone ( Supplementary Fig. 2 ) and indicated no direct or indirect contacts to DNA ( Figs. 1a and 2a) . The HSF2 wing domain is formed, in part, by a hydrogen bond between His74 and Glu89 that acts as a wedge between β sheets that 'pries open' the wing domain for solvent exposure ( Fig. 2b) . Additionally, Asp86 engages in a hydrogen bond to Asn56 of the adjacently bound monomer, establishing an HSF2 dimer interface also observed in the K. lactis structure ( Fig. 2c) ; formation of this interface has been proposed to be the primary function of the wing domain 8 . Moreover, the side chain of HSF2 DBD Lys82, identified by in vivo proteomic studies to be covalently conjugated by SUMO2 (refs. 30-32), is exposed to solvent ( Fig. 2a) . The importance of the wing domain is underscored by a report demonstrating that replication protein A subunit 70 kDa (RPA70) binds to the HSF1 wing domain but not to HSF2 (ref. 33) . By analogy with the HSF2 DBD structure presented here, the location of the RPA70 interaction with HSF1 has been predicted to occur at the most distal portion of the wing domain, where little steric hindrance would be observed. The structural findings described here, together with earlier published functional studies, suggest that the HSF wing domain has a critical npg a r t i c l e s regulatory role and provides a specificity component for distinct HSF family members. These regulatory events are probably enabled by the unique structural features of the HSF wing domain; these features are strikingly different from those of other members of the winged helix-turn-helix DBD family, which use the wing domain to contact DNA 28, 29 .
HSF2 DBD directs wrapping of the coiled coil around DNA Current models for the topology of HSFs bound to DNA posit that the coiled-coil multimerization domain sits atop the DBD, thus poising the transactivation region for interactions with the transcriptional machinery 1,3,34 . We observed that a C-terminal helix, which is present on the outer region of the HSF2 DBD ( Fig. 3a) , and Phe96, which precedes this helix, are inserted into a deep hydrophobic pocket in the DBD formed by Leu14, Trp15, Trp29 and Phe35 (Fig. 3b ). Gly99 enables a hairpin turn into the helix that is formed by the amphipathic sequence LLENI and is directed toward the 'bottom' half of the DNA. The hydrophobic surface of this sequence fits into a hydrophobic pocket in the core of the DBD, thereby directing the helix 'down' to the opposite side of DNA ( Fig. 3a,b ). In addition, two conserved residues following the helix, Arg109 and Lys110, contact the DNA phosphate backbone, thus further directionally stabilizing the region preceding the coiled-coil multimerization domain on the opposite side of the DNA ( Fig. 3a and Supplementary Fig. 3a,b) . Key residues involved in the architecture of this C-terminal helix are conserved throughout HSF species, thus suggesting conservation of the directionality of the coiled-coil multimerization domain ( Supplementary Fig. 3c ).
HSFs are thought to exist as trimeric proteins, on the basis of the tripartite nature of a canonical HSE (NNGAANNTTCNNGAANN), their apparent electrophoretic mobility in heat-shocked cell extracts and the presence of an extended coiled-coil immediately downstream of the DBD 10, 35, 36 . To gain insights into the structural features of the DBD topology in an HSF trimer, we solved the crystal structure of the HSF2 DBD bound to a canonical three-site HSE ( Table 1 and Supplementary Fig. 3d ). Interestingly, the HSF2 DBD crystallized in the P1 space group with two dimers bound to two three-site HSEs (Fig. 3c) , thus demonstrating that even when presented with a tripartite HSE, the HSF2 DBD crystallized as a dimer, with the third Figure 2 The HSF2 wing domain is solvent exposed and does not contact DNA. (a) Side view of the HSF2 DBD with the wing domain indicated on the left and the recognition helix inserted into the major groove of the HSE DNA site. Lys82, depicted as a stick model, is directed away from the DNA and exposed for modification. (b) His74 and Glu89 form a hydrogen bond that acts as a wedge that pries open the wing domain. (c) Asp86 engages Asn56 from the adjacent monomer, thus forming a hydrogen bond that is predicted to strengthen the dimer interface and anchor the wing domain. Fig. 3e ). Furthermore, all C-terminal helices of the HSF2 DBD are directed to the opposite side of the DNA, similarly to those in to the two-site HSE structure ( Fig. 3c) . Although it is possible that the dimer structure observed here occurs as a function of crystal packing, HSF oligomeric states may exist outside of the canonical trimer, as has been suggested for HSF2 dimers in K562 cells 37 .
The HSF2 coiled-coil multimerization domain is located C terminal to the DBD and is separated by a short linker sequence of 14 amino acids. From both the HSF2 DBD two-site and three-site structures, we propose that the conserved C-terminal amphipathic helix directs the extended coiled coil opposite the DNA, thereby allowing HSFs to wrap around the DNA upon binding. This topology would permit the upper surface of the HSF DBD to be accessible for regulatory interactions that would otherwise be sterically occluded by the multimerization domain, as depicted in current models 3, 7, 34, 38, 39 . This topology presents surfaces for geographically distinct interactions with regulatory proteins via both the DBD and the coiled-coil domain in proximity to DNA. Support for this model is rooted in reports that have identified key interactions and post-translational modifications that occur within both the DNA-binding and coiled-coil domains of transcription factors including HSF1 (refs. 33, [40] [41] [42] . Thus, embracing of DNA by HSF family members would enable geographically separated regulatory interactions at both the DBD and coiled-coil domain that would provide multiple input signals for HSF-mediated regulation. Given this new structural information, we propose a new model for the geometry of HSF bound to DNA; our model is inverted with respect to previous models 1, 43 .
HSFs exhibit divergent surface characteristics distal to DNA
A comparison of the structures of the HSF2 DBD bound to DNA with the sequences of the HSF1 and HSF4 DBDs suggests that these proteins interact with DNA in a highly similar manner. To explore the nature of HSF family DBD surface features, we calculated the relative conservation of individual amino acids between HSF paralogs by using the ConSurf Server 44 . On the HSF2 surface that contacts DNA, it was apparent that amino acid residues such as Arg63 and other residues making direct and indirect DNA contacts are conserved ( Fig. 4) . This conservation suggests that HSF family members would have few, if any, paralog-specific sequence preferences for DNA and provides support for extrinsic mechanisms driving differential target-gene binding and activation in vivo. Examination of the HSF DBD surface distal to DNA contact sites showed little conservation of sequence or biochemical character ( Fig. 4) , thus suggesting that HSFs S1  S2  S1  S2  S1  S2  S1  S2  SUMO  1 or 2   1W2 DBD  2W1 DBD  HSF  2 have evolved distinct surfaces to accommodate divergent regulatory inputs within the DBD, without altering DNA binding mechanisms. Furthermore, the wrapping of HSF coiled-coils around HSE DNA would expose the wing and other unique surfaces of the HSF1, HSF2 and HSF4 DBDs, thus generating a template for additional paralogspecific interactions with regulatory proteins.
HSF1 and HSF2 are differentially SUMOylated in vitro
The HSF1 DBD, but not the HSF2 DBD, has previously been shown to interact with RPA70 in vitro and in vivo, and this interaction contributes to HSF1-mediated target-gene expression 35 . We postulated that a distinct protein-protein interaction or post-translational modification might be specific for the HSF2 DBD. Reports describing the mammalian SUMOylated proteome have found that Lys82 of HSF2 is conjugated by SUMO2 but have not identified the corresponding Lys91 of HSF1 (refs. [30] [31] [32] . Because HSF2 Lys82 localizes within the exposed wing domain (Fig. 2a) , we ascertained whether there is intrinsic SUMOylation specificity between the HSF1 and HSF2 DBDs. SUMOylation is analogous to ubiquitination in that both processes use an E1-E2-E3 enzymatic cascade for covalent modification of lysine on substrate proteins 31, 45 . In addition, mammals have three distinct SUMO paralogs, SUMO1, SUMO2 and SUMO3; SUMO2 and SUMO3 are similar and impart different functional consequences from those of SUMO1 (ref. 30 ). Using recombinant SUMO E1 (SAE1 and SAE2), SUMO E2 (Ubc9) and SUMO E3 (RANBP∆FG) enzymes, we examined whether SUMO1 or SUMO2 could be covalently attached to the HSF1 or HSF2 DBD in vitro. The HSF1 DBD showed little to no modification by SUMO1 or SUMO2, whereas the HSF2 DBD was efficiently modified by both SUMO paralogs (Fig. 5a) . This result was recapitulated when we performed the SUMO reactions with the SUMO E3 ligase PIAS1 or without E3 ligase (Supplementary Fig. 4a) . Because SUMO proteomics studies have identified Lys82 in the HSF2 wing domain as a SUMO substrate, we constructed wing-domain chimeras in which the HSF1 DBD contained the HSF2 wing domain (HSF1W2) or the HSF2 DBD contained the HSF1 wing domain (HSF2W1) ( Fig. 5b and Supplementary Fig. 4b) . The HSF1W2 and HSF2W1 chimeras displayed opposite SUMOylation phenotypes from those of their wild-type (WT) counterparts, thus demonstrating that the HSF1 and HSF2 wing domains have distinct and transportable biochemical features that drive differential SUMOylation in vitro and in vivo. The HSF4 DBD does not contain a lysine in the wing domain ( Supplementary Fig. 4b) , thus rendering this wing domain incompetent for SUMO modification. The distinct SUMOylation profiles of HSF1, HSF2 and HSF4, and the HSF1-specific interaction with RPA70 within the wing domain, may partly underlie regulatory differences that impart target-gene selectivity in vivo [46] [47] [48] [49] .
The wing domain regulates HSF activity in vivo
To explore a potential role for the wing domain in differential HSF function in vivo, we expressed triple FLAG (3×FLAG)-tagged derivatives of WT HSF1, HSF1W2, HSF2 or HSF2W1 proteins in mouse embryonic fibroblasts (MEFs) doubly knocked out for HSF1 and HSF2 (Fig. 5c-e ). Under control conditions, in vivo DNA binding activity of WT HSF1 and HSF1W2 were indistinguishable at the Hsp70, Hsp25 and interleukin-6 (IL-6) promoters (Fig. 5c) . In contrast, WT HSF2 but not HSF2W1 exhibited basal binding to the Hsp70, Hsp25 and IL-6 promoters, thus suggesting that the endogenous HSF2 wing domain is essential for basal HSF2 DNA binding (Fig. 5c) . Interestingly, under heat-shock conditions, HSF1W2 was compromised in binding to the Hsp70 promoter (approximately three-fold reduction) and the Hsp25 promoter (approximately fivefold reduction), whereas DNA binding was unaffected at the IL-6 promoter (Fig. 5c) . These results suggest that the HSF wing domains have genomic locus-specific effects on DNA binding. Importantly, differences in the DNA binding of HSF DBD wing-domain chimeras in vivo were not explained by differences in DNA binding to an HSE in vitro (Supplementary Fig. 4c) .
Analogously to the DNA binding of HSF wing-domain chimeras, expression of Hsp70, Hsp25 and IL-6 mRNA was unchanged in cells expressing WT HSF1 compared to HSF1W2 under control conditions (Fig. 5d) . Upon heat shock, HSF1W2 was compromised in its ability to induce expression of Hsp70 (~37% of WT) and Hsp25 (~21% of WT) but not IL-6, thus suggesting that the HSF wing domain has genomic locus-specific effects on target-gene expression ( Fig. 5d) . Expression of both WT HSF2 and HSF2W1 did not increase expression of Hsp70, Hsp25 or IL-6 mRNA over that in vector-transfected cells, thus raising the possibility that HSF2 does not exhibit activity at these loci in the absence of HSF1. The analyses of DNA binding and gene expression were further supported by immunoblotting, in which cells expressing HSF1W2, compared to WT HSF1, were strongly compromised for activation of Hsp70 expression after exposure to proteotoxic conditions induced by heat shock or the proteasome inhibitor MG132 (Fig. 5e) . Moreover, neither WT nor chimeric HSF2 activated Hsp70 expression after heat shock or proteasome inhibition, although their protein levels were similar to those of the HSF1 variants (Fig. 5e) . Together, these results suggest that the HSF wing domain has a locus-specific biological function that does not involve direct DNA contacts, and they lay the foundation for mechanistic studies of critical regulatory events that occur within the HSF wing domains. 
HSF1 and HSF2 directly interact and form heterocomplexes
Several reports have documented an interaction between HSF1 and HSF2 in vivo through coimmunoprecipitation and electrophoretic mobility supershift assays, approaches that do not distinguish between direct and indirect interactions 22, 26, 27 . To ascertain whether HSF1 and HSF2 directly interact, we coexpressed StrepII-tagged human HSF1 and hexahistidine (His 6 )-tagged human HSF2 in Escherichia coli from a single plasmid with a bidirectional promoter ( Supplementary Fig. 5a ). Tandem differential affinity purification resulted in coelution of HSF1 and HSF2, thus suggesting that the two proteins directly interact (Fig. 6a) . We fractionated the HSF1-HSF2 heterocomplexes by gel filtration, which resolves monomeric and multimeric HSF1 (ref. 4 ). The HSF1-HSF2 complex copurified at an elution volume similar to that of the HSF1 multimer, thus demonstrating that HSF1 and HSF2 form heteromultimeric complexes that are stable through three tandem purification steps ( Fig. 6b and Supplementary Fig. 5b ). Cross-linking and mass spectrometry confirmed that HSF1 and HSF2 were the only nonkeratin proteins detectable in cross-linked complexes ( Supplementary Fig. 5c and Supplementary Data Set 1).
We evaluated the possibility that the HSF1-HSF2 interaction is mediated by the extended coiled-coil domain (LZ1-3) contained in both HSF1 and HSF2. We expressed plasmids containing HSF1∆LZ1-3 and WT HSF2 (Dual ∆1) and the reciprocal HSF1 and HSF2∆LZ1-3 (Dual ∆2) and purified them as in Figure 6a . WT HSF1 and HSF2 copurified from cell lysates (Dual), but WT HSF2 failed to copurify with HSF1 ∆LZ1-3 (Dual ∆1), and WT HSF1 did not copurify with HSF2 ∆LZ1-3 (Dual ∆2) ( Fig. 6c and Supplementary Fig. 5d ). These results demonstrate that HSF1 and HSF2 form heterocomplexes directly through their respective extended coiled-coil multimerization domains in a fashion similar to that of other coiled-coil transcriptionfactor multimers such as c-Fos and c-Jun 40 . To validate the direct interaction between HSF1 and HSF2, we performed coimmunoprecipitation experiments in Hsf1 −/− Hsf2 −/− MEFs expressing hemagglutinin (HA)-tagged HSF1 alone, WT HSF2 or HSF2 ∆LZ1-3. HSF1 specifically coprecipitated with WT HSF2 but not HSF2 ∆LZ1-3, thus demonstrating that the HSF2 coiled-coil domain is indispensable for the HSF1 interaction in vitro and in vivo (Fig. 6d) . Together, these observations suggest that in the context of the HSF coiled-coil npg a r t i c l e s wrapping around DNA, HSF1-HSF2 interactions would provide a template for additional differential and combinatorial regulatory events that would not exist in HSF1 or HSF2 homo-oligomeric complexes. Here, we present a new model for HSF DNA binding, using a generic coiled-coil domain 50 , in which the coiled-coil domain of homomultimeric HSF2 embraces DNA (Fig. 7) . A similar model for an HSF1-HSF2 heteromultimer bound to DNA enables combinatorial interactions between HSF1 complexes (RPA70 and SSBP1) and HSF2 (SUMO) regulatory modules 33, 41, 42 (Fig. 7) . The direct interaction between HSF1 and HSF2 also enables combinatorial regulation at other domains including the regulatory domain, LZ4 and activation domain.
DISCUSSION
The HSF2 DBD structures presented in this study lay the foundation for a better understanding of how HSFs enable complex and dynamic regulation at diverse genomic loci in distinct cellular contexts. Distinct biochemical features of HSF DBDs distal to the DNA-binding surface drive differential post-translational modifications and proteinprotein interactions. Such differential regulation would be enabled by the wrapping of HSFs around DNA, thus presenting divergent and geographically separated surfaces, including both the DBDs and coiled-coil domains, for regulatory inputs. Further exploration into the divergent surfaces of HSF family members may reveal additional paralog-specific regulatory events that enable complex transcriptional regulation that could not be achieved via subtle variations in genomic HSE sequences.
The evolution of transcriptional regulatory networks has been proposed to occur through variation in cis-regulatory elements upstream of target genes 51 , because mutations in transcriptional regulators themselves would have the potential for widespread consequences in comparison to single mutations in the regulatory sequences of specific genes. However, a growing body of evidence suggests that variations in transcription factors themselves can drive complex regulation of gene-expression networks and can be enabled through gene duplication events 52, 53 . We suggest that the human HSF family represents a quintessential example of this type of transcriptional-network evolution.
The evolution of the conserved and unique surfaces of human HSF paralogs resembles the evolution of MADS-box proteins in yeast, in which gene duplication has enabled the neofunctionalization of MADS-box paralogs in Saccharomyces cerevisiae compared to yeasts harboring a single MADS-box protein 54 . For example, the S. cerevisiae Mcm1 and Arg80 MADS-box paralogs maintain similar DNA binding preferences but exhibit diversity in cofactor-binding pockets, and interactions between Mcm1 and Arg80 facilitate combinatorial regulation 54 . A similar phenomenon might occur with HSFs, in which HSF1 and HSF2 would exhibit paralog interactions that influence the activity of each individual paralog.
The direct physical and functional interactions between HSF1 and HSF2 add an additional layer of complexity to the stress response but may also provide cells with a rheostat facilitating more precise transcriptional output at specific HSF-target genes or other chromosomal loci. HSF1 is known to function in protein-misfolding diseases and to drive a unique gene-expression program in cancer cells, whereas HSF2 has recently been proposed to act as a tumor suppressor, thus highlighting the importance of understanding differential HSF regulation 55 . A better understanding of such regulatory features may enable the design and development of selective molecular probes that target specific arms of the HSF-mediated transcriptional program. The transcriptional outcome of the direct interaction between HSF1 and HSF2, and the consequential regulatory interactions, present an intricate mechanism that could affect a diverse array of normal and pathophysiological cellular processes. Further exploration of surface features of the HSFs, and other transcription factors, may reveal new layers of transcriptional outputs that influence cellular processes and new ways to modulate these complex regulatory interactions.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes PDB 5D8K (HSF2 DBD bound to two-site HSE) and PDB 5D8L (HSF2 DBD bound to three-site HSE).
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. 
